Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Clinical trial NCT04294459 · TERMINATED

Trial details

NCT number: NCT04294459
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immune System Disorder

Start date: 2020-06-18
Primary completion: 2022-05-02
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.